Part D/Prescription Drugs

(By Rebecca Robbins for STAT) Mylan Pharmaceuticals has spent millions this year on television ads and celebrity testimonials that implicitly promote the EpiPen — without

(By Martha Bebinger, WBUR for Kaiser Health News) Some arrive on their own, worried about what was really in that

(By Ed Silverman for STAT) While anger is directed at Mylan Pharmaceuticals over the rising cost of its EpiPen device,

(By Katherine Hobson for NPR) Federal data suggest illegally manufactured fentanyl, a drug that is 50 to 100 times stronger

(By Michelle Andrews for Kaiser Health News) As prescription drug costs continue to rise, ensuring that consumers have access to

(By Ed Silverman for STAT) As cancer treatments become both more innovative and costlier, a new study finds that most

(Ed Silverman for STAT) In the face of withering criticism, Mylan Pharmaceuticals took steps Thursday to make its EpiPen device more affordable. Specifically, the

(By Sydney Lupkin for Kaiser Health News) The “most important factor” that drives prescription drug prices higher in the United

(By Scott Gottlieb, MD for AEI) One of the biggest factors fueling the angst over drug prices in the U.S.